This advanced continuing medical education activity, taking place at the historic Roosevelt Hotel in midtown Manhattan, New York, will provide participants with state-of-the-art education and practical guidance from nationally and internationally recognized experts on hepatitis C virus infection.

The primary goals of this activity are to increase each attendee’s competence to:

•  Recognize the indications for HCV treatment and delineate therapeutic options for treatment

•  Distinguish options for disease staging in patients with hepatitis C

•  Explain barriers to effective care of patients with hepatitis C

•  Apply new information to manage disease in difficult-to-treat populations

•  Recognize conditions for development of resistance to antiviral therapy

•  Illustrate possible treatment interactions with other drug therapies and issues affecting drug metabolism

•  Identify viral targets of current and new therapies

As we enter the fifth year of HEPATITIS C MANAGEMENT – STATE OF THE ART, enormous progress continues to be made in the treatment of this disease. A rapidly increasing number of treatment options require practitioners to continually update their knowledge about the potential benefits and pharmacology of various hepatitis C therapies. These therapies, as well as their side effects and effectiveness, make the decision to treat individual patients more complex. They require the practitioner to possess a sophisticated understanding of the natural history of the disease, viral resistance to therapy, and management requirements of various patient populations with hepatitis C.